Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01984671
Other study ID # Pro00047952
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 12, 2013
Est. completion date October 15, 2015

Study information

Verified date August 2023
Source Duke University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Persistent pain is a major challenge for patients who undergo hematopoietic stem cell transplant (HSCT) and is related to more fatigue, more physical disability, poorer quality of life, and poorer medical adherence. There is a need to examine strategies for managing pain in HSCT patients that can complement existing analgesic regimens. Strong evidence suggests that cognitive and behavioral factors play an important role in HSCT patients' ability to manage their pain. The investigator has found that HSCT patients having low levels of confidence (i.e., self-efficacy) in their ability to control pain and high use of maladaptive coping strategies (i.e., pain catastrophizing) experience increased pain and disability. A psychosocial intervention that modifies patients' cognitive and behavioral pain coping strategies may benefit HSCT patients. Protocols, particularly Pain Coping Skills Training (PCST), have been developed for reducing pain and improving quality of life in patients with persistent pain. However, HSCT patients with persistent pain face a number of unique challenges that must be considered when applying a PCST protocol. The investigator proposes to develop and test a Mobile Health Pain Coping Skills (mPCST) protocol for HSCT patients with persistent pain to meet the challenges of HSCT patients with pain as they transition from hospital based care to their home environment. The first aim of this study is to use an iterative development model to design a mPCST intervention protocol for HSCT patients that targets increasing self-efficacy for pain control and decreasing pain catastrophizing. The study team will use focus groups with patients and HSCT providers to guide development along with user testing with HSCT patients having pain. The second aim of this study is to use a small randomized controlled trial to examine the feasibility, acceptability, and engagement in the developed mPCST protocol. The third aim is to obtain an estimate of the effect size of the developed mPCST protocol on decreased pain, pain disability, physical disability, and adherence to post-transplant lifestyle recommendations impacted by pain when compared to a standard care control condition. Proposed innovative features of the mPCST protocol that will be developed include: extensive input from PCST and HSCT experts and HSCT patients with pain; an initial session prior to discharge with subsequent sessions occurring at home via video-conferencing; incorporation of strategies to decrease the impact of pain on adherence to critical post-transplant lifestyle recommendations; a real-time daily assessment system with subsequent tailored feedback. If the developed mPCST protocol demonstrates feasibility, acceptability, engagement, and promising effect sizes to influence pain and other indices of quality of life, a larger NIH grant will be sought to examine this protocol in a larger sample of patients, test the protocol against an active treatment, and investigate a broader array of outcomes (e.g., medication adherence). This mPCST protocol could also be examined in other patient populations with pain facing similar challenges (e.g., live far from medical center, travel limitations).


Recruitment information / eligibility

Status Completed
Enrollment 72
Est. completion date October 15, 2015
Est. primary completion date October 15, 2015
Accepts healthy volunteers No
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: 1. receipt of an stem cell transplant due to an oncological disease, 2. no prior stem cell transplant, 3. report a clinical pain score of > 3/10, and 4. an age of >21.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Mobile Pain Coping Skills Training


Locations

Country Name City State
United States Duke University Medical Center Durham North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Duke University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Accrual Accrual into this study will be used as the main outcome measure to examine feasibility of the intervention. 22 months
Secondary Pain Levels Pain as measured by the Brief Pain Inventory. 22 months
See also
  Status Clinical Trial Phase
Completed NCT03641378 - Inpatient Palliative Care for Patients Undergoing Hematopoietic Stem Cell Transplantation N/A
Recruiting NCT06155188 - Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia N/A
Recruiting NCT03562065 - Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord Phase 1/Phase 2
Completed NCT01468935 - Bone Marrow Cell Engraftment of the Uterus and Genetic Studies of Reproductive Functioning
Active, not recruiting NCT03938324 - Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions N/A
Completed NCT04219657 - Comparison Between Skin Graft Versus Skin Graft and Stem Cell Application Phase 1
Not yet recruiting NCT03259217 - Clinical Application of Mesenchymal Stem Cells Seeded in Chitosan Scaffold for Diabetic Foot Ulcers Phase 1
Recruiting NCT01189786 - Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection N/A
Recruiting NCT04610359 - Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis Phase 1
Completed NCT05712148 - Spheroidal Mesenchymal Stem Cells in Retinitis Pigmentosa Phase 1/Phase 2
Recruiting NCT05515497 - BMT4me: Post-HSCT Medication Adherence mHealth App N/A
Not yet recruiting NCT06075927 - Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT Phase 1/Phase 2
Completed NCT03440775 - Digital Stories and Psychosocial Wellbeing in Stem Cell Transplant Patients N/A
Recruiting NCT02652052 - Hematopoietic Stem Cell Transplant Survivors Study N/A
Not yet recruiting NCT04922970 - Strength Training as Prevention and Treatment of Late Effects in Long-term Survivors of Pediatric HSCT. N/A
Completed NCT01092195 - Gardasil Vaccination in Post Stem Cell Transplant Patients Phase 1
Completed NCT04041219 - Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients Phase 4
Completed NCT00656058 - Montelukast to Treat Bronchiolitis Obliterans Phase 2
Recruiting NCT04375579 - Assessment of Elderly Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Completed NCT03859765 - In Person and mHealth Coping Skills Training for Symptom Management and Steps in Stem Cell Transplant Patients N/A